Spinal Tech

Stryker has sold its bone morphogenetic protein-7 assets to Mariel Therapeutics. The companies entered into a definitive agreement announced yesterday.

Benvenue Medical named 20-year industry veteran Jeffrey Jones chief operating officer.

Munich Innovation, based in Germany, plans to acquire the Magnetodyn patented portfolio of bone and tissue regeneration technology.

NuVasive named Carol Cox executive vice president of strategy and corporate communications, reporting directly to chairman and CEO Alex Lukianov.

MicroPort Orthopedics and MB Innovations entered into a multi-product development agreement for orthopedic instruments, according to a Pharmiweb report.

Exactech Executive Vice President Gary J. Miller sold 12,392 more shares of the company's stock last Tuesday, according to a Mideast Times report.

Medical device company Mainstay Medical International has submitted a Pre-Investigational Device Exemption information package to the FDA for its implantable neurostimulation device ReActiv8.

Spine device company NuVasive plans to open an international operations center in Waterford, Ireland, according to a Silicon Report article.

Mazor Robotics reported four Renaissance Systems were sold during the second quarter of 2014.

More than two months after Zimmer announced intentions to acquire Biomet, the United States Federal Trade Commission requested additional information on the companies.